New Hansa CEO Outlines Hopes And Plans For 2020 Lead Asset Launch

 
• By Sten Stovall

Søren Tulstrup says Hansa remains confident of achieving at least a conditional approval for lead asset IdeS, with potential renal transplant launch by early 2020. 

Soren Tulstrup
Søren Tulstrup, Hansa is President and CEO of Hansa Medical effective March 20 • Source: Hansa Medical AB

More from Strategy

More from Business